VIVUS, Inc. (VVUS) Shares Jump 26%
VIVUS, Inc. (NASDAQ:VVUS) shares jumped 26.43% to $7.75 on Friday after the company announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA decided that the NDA cannot be approved in [...]
Notable Healthcare Stocks Gainers (PIP, SUPG, VVUS, KCI)
PharmAthene, Inc. (AMEX:PIP) surged 8.50% to $4.34 on a volume of 3.82 million shares. The stock today also touched a new 52-week high at $4.96. So far in this year the stock has soared 80%. PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons. [...]